KCRN Research   Report issue

For profit Phase 1 Phase 2
Founded: Germantown MD United States (2012)

Organization Overview

First Clinical Trial
2016
NCT02674399
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

KCRN Research | KCRN Research, LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Colitis, Ulcerative (Phase 1)

Idiopathic Pulmonary Fibrosis (Phase 1)

Neoplasms (Phase 1)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Pulmonary Fibrosis (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 8
  • # of Trial APIs: 9